Buy MRPL; target of Rs 81: IIFL

Published on Mon, Jun 06, 2011 at 12:28 |  Source : Moneycontrol.com

Updated at Mon, Jun 06, 2011 at 12:58  

18847 Investors following MRPL. Share this News with them.
0
0
Share on Tumblr
Buy MRPL; target of Rs 81: IIFL

RELATED NEWS

ALSO READ

IIFL is bullish on MRPL and has recommended buy rating on the stock with a target of Rs 81 in its June 6, 2011 research report.

"Daily chart of MRPL depicts a bullish Inverted Head and Shoulder formation with prices crossing above the neckline of Rs 76 in Friday's session. The stock last week, saw a sharply rally from its 200-DMA with higher-than-average volumes, which is likely to act as a strong support on any declines. Friday's breakout exhibits strength on the medium term charts as Rs 76 was acting as a stiff resistance from November 2010. Going forward, the implication of inverted head & shoulder pattern suggest that stock is likely to rally towards Rs 84, before finding next leg of resistances. Based on above mentioned technical evidences, we recommend traders to buy the stock between Rs 75.50-76 with stop loss of Rs 74 for target of Rs 81," says IIFL research report.

What stocks does Deutsche hold?

Disclaimer: The views and investment tips expressed by investment experts on moneycontrol.com are their own, and not that of the website or its management.Moneycontrol.com advises users to check with certified experts before taking any investment decisions.

To read the full report click on the attachment

Attachments : MRPL_IIFL_060611.pdf

  

Trending News

Business News

Google ChromeOS goes big with Chromebox, new Chromebook
Did Sebi miss any tricks in Ambani consent order? "Did Sebi miss any tricks in Ambani consent order?"

Oppn gears up to make Bharat bandh a success

Barack Obama Says US Economy Still Delicate Because Of Euro Zone Crisis

The latest earning numbers FIRST on CNBC-TV18
Videos

May 30 2012, 11:18

Result corner: Ajay Bodke`s top bets from across sectors

- in MARKET OUTLOOK

Interviews

May 30 2012, 17:04 | Source: CNBC-TV18

Margins may be hit on one-off items in EBITDA: Sun Pharma  

May 30 2012, 16:32 | Source: CNBC-TV18

Essar announces Rs 175cr deal; to pay-off debts with fund  

Subscribe to

Moneycontrol Newsletters

Moneycontrol.com offers you a choice of various sectoral and other newsletters for FREE!